BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lian J, Huang X, Pai N, Deng C. Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications. Pharmacological Research 2016;106:51-63. [DOI: 10.1016/j.phrs.2016.02.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Luo C, Wang X, Huang H, Mao X, Zhou H, Liu Z. Effect of Metformin on Antipsychotic-Induced Metabolic Dysfunction: The Potential Role of Gut-Brain Axis. Front Pharmacol 2019;10:371. [PMID: 31024322 DOI: 10.3389/fphar.2019.00371] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
2 Khanfar MA, Affini A, Lutsenko K, Nikolic K, Butini S, Stark H. Multiple Targeting Approaches on Histamine H3 Receptor Antagonists. Front Neurosci 2016;10:201. [PMID: 27303254 DOI: 10.3389/fnins.2016.00201] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
3 Connor CJ. Management of the psychological comorbidities of dermatological conditions: practitioners' guidelines. Clin Cosmet Investig Dermatol 2017;10:117-32. [PMID: 28458571 DOI: 10.2147/CCID.S111041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Mika K, Szafarz M, Sapa J, Kotańska M. Influence of betahistine repeated administration on a weight gain and selected metabolic parameters in the model of excessive eating in rats. Biomed Pharmacother 2021;141:111892. [PMID: 34229247 DOI: 10.1016/j.biopha.2021.111892] [Reference Citation Analysis]
5 Youssef DA, El-fayoumi HM, Mahmoud MF. Beta-caryophyllene alleviates diet-induced neurobehavioral changes in rats: The role of CB2 and PPAR-γ receptors. Biomedicine & Pharmacotherapy 2019;110:145-54. [DOI: 10.1016/j.biopha.2018.11.039] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
6 Han M, Lian J, Su Y, Deng C. Cevimeline co-treatment attenuates olanzapine-induced metabolic disorders via modulating hepatic M3 muscarinic receptor: AMPKα signalling pathway in female rats. J Psychopharmacol 2021;:2698811211050549. [PMID: 34694173 DOI: 10.1177/02698811211050549] [Reference Citation Analysis]
7 Liu Z, Cui C, Xu P, Dang R, Cai H, Liao D, Yang M, Feng Q, Yan X, Jiang P. Curcumin Activates AMPK Pathway and Regulates Lipid Metabolism in Rats Following Prolonged Clozapine Exposure. Front Neurosci 2017;11:558. [PMID: 29046626 DOI: 10.3389/fnins.2017.00558] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
8 Verhaegen AA, Van Gaal LF. Drugs Affecting Body Weight, Body Fat Distribution, and Metabolic Function-Mechanisms and Possible Therapeutic or Preventive Measures: an Update. Curr Obes Rep 2021;10:1-13. [PMID: 33400222 DOI: 10.1007/s13679-020-00419-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
9 Perez-Gomez A, Carretero M, Weber N, Peterka V, To A, Titova V, Solis G, Osborn O, Petrascheck M. A phenotypic Caenorhabditis elegans screen identifies a selective suppressor of antipsychotic-induced hyperphagia. Nat Commun 2018;9:5272. [PMID: 30532051 DOI: 10.1038/s41467-018-07684-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
10 Liu XM, Zhao XM, Deng C, Zeng YP, Hu CH. Simvastatin improves olanzapine-induced dyslipidemia in rats through inhibiting hepatic mTOR signaling pathway. Acta Pharmacol Sin 2019;40:1049-57. [PMID: 30728467 DOI: 10.1038/s41401-019-0212-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
11 Zhao YX, Pan JB, Wang YN, Zou Y, Guo L, Tang QQ, Qian SW. Stimulation of histamine H4 receptor participates in cold-induced browning of subcutaneous white adipose tissue. Am J Physiol Endocrinol Metab 2019;317:E1158-71. [PMID: 31550180 DOI: 10.1152/ajpendo.00131.2019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
12 Mukherjee S, Skrede S, Milbank E, Andriantsitohaina R, López M, Fernø J. Understanding the Effects of Antipsychotics on Appetite Control. Front Nutr 2021;8:815456. [PMID: 35047549 DOI: 10.3389/fnut.2021.815456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Chen J, Huang XF, Shao R, Chen C, Deng C. Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes. Front Neurosci 2017;11:643. [PMID: 29209160 DOI: 10.3389/fnins.2017.00643] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
14 Marteene W, Winckel K, Hollingworth S, Kisely S, Gallagher E, Hahn M, Ebdrup BH, Firth J, Siskind D. Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia. Expert Opin Drug Saf 2019;18:1149-60. [PMID: 31564170 DOI: 10.1080/14740338.2019.1674809] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
15 Citrome L, McEvoy JP, Todtenkopf MS, McDonnell D, Weiden PJ. A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future. Neuropsychiatr Dis Treat 2019;15:2559-69. [PMID: 31564881 DOI: 10.2147/NDT.S209284] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
16 Salvi V, Mencacci C, Barone-Adesi F. H1-histamine receptor affinity predicts weight gain with antidepressants. Eur Neuropsychopharmacol 2016;26:1673-7. [PMID: 27593622 DOI: 10.1016/j.euroneuro.2016.08.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
17 Garriga M, Mallorquí A, Serrano L, Ríos J, Salamero M, Parellada E, Gómez-ramiro M, Oliveira C, Amoretti S, Vieta E, Bernardo M, García-rizo C. Food craving and consumption evolution in patients starting treatment with clozapine. Psychopharmacology 2019;236:3317-27. [DOI: 10.1007/s00213-019-05291-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
18 Shi H, Wang B, Niu L, Cao M, Kang W, Lian K, Zhang P. Trace level determination of 5-hydroxytryptamine and its related indoles in amniotic fluid by gas chromatography–mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2017;143:176-82. [DOI: 10.1016/j.jpba.2017.05.044] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
19 Dayabandara M, Hanwella R, Ratnatunga S, Seneviratne S, Suraweera C, de Silva VA. Antipsychotic-associated weight gain: management strategies and impact on treatment adherence. Neuropsychiatr Dis Treat 2017;13:2231-41. [PMID: 28883731 DOI: 10.2147/NDT.S113099] [Cited by in Crossref: 83] [Cited by in F6Publishing: 38] [Article Influence: 16.6] [Reference Citation Analysis]
20 Manolis TA, Manolis AA, Manolis AS. Cardiovascular Safety of Psychiatric Agents: A Cautionary Tale. Angiology 2019;70:103-29. [PMID: 29874922 DOI: 10.1177/0003319718780145] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
21 Li WT, Huang XF, Deng C, Zhang BH, Qian K, He M, Sun TL. Olanzapine Induces Inflammation and Immune Response via Activating ER Stress in the Rat Prefrontal Cortex. Curr Med Sci 2021;41:788-802. [PMID: 34403105 DOI: 10.1007/s11596-021-2401-7] [Reference Citation Analysis]
22 Deng C, Yao JK. Editorial: Metabolic Disturbances in Mental Illness: Neuropathogenetic Mechanisms and Therapeutic Implications. Front Neurosci 2020;14:21. [PMID: 32063831 DOI: 10.3389/fnins.2020.00021] [Reference Citation Analysis]
23 Smith RC, Maayan L, Wu R, Youssef M, Jing Z, Sershen H, Szabo V, Meyers J, Jin H, Zhao J, Davis JM. Betahistine effects on weight-related measures in patients treated with antipsychotic medications: a double-blind placebo-controlled study. Psychopharmacology 2018;235:3545-58. [DOI: 10.1007/s00213-018-5079-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
24 Naguy A, Alshalabi SR, Alkhadhari S. Betahistine-Associated Weight Loss and Improved Cognitive and Negative Symptoms: Domain in Early-Onset Schizophrenia. American Journal of Therapeutics 2019;26:e790-2. [DOI: 10.1097/mjt.0000000000000965] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
25 Singh R, Bansal Y, Sodhi RK, Saroj P, Medhi B, Kuhad A. Modeling of antipsychotic-induced metabolic alterations in mice: An experimental approach precluding psychosis as a predisposing factor. Toxicology and Applied Pharmacology 2019;378:114643. [DOI: 10.1016/j.taap.2019.114643] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
26 Chen X, Yu Y, Zheng P, Jin T, He M, Zheng M, Song X, Jones A, Huang X. Olanzapine increases AMPK-NPY orexigenic signaling by disrupting H1R-GHSR1a interaction in the hypothalamic neurons of mice. Psychoneuroendocrinology 2020;114:104594. [DOI: 10.1016/j.psyneuen.2020.104594] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Poyurovsky M, Weizman A. Beneficial Effect of Betahistine, a Structural Analog of Histamine, in Clozapine-Related Sedation. Clin Neuropharm 2019;42:145-145. [DOI: 10.1097/wnf.0000000000000346] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
28 Suhas S, Shivani S, Singh GK, Venkatasubramanian G. Festina Lente: Betahistine for Clozapine-Associated Weight Gain: A Case Report. J Clin Psychopharmacol 2021;41:332-3. [PMID: 33843821 DOI: 10.1097/JCP.0000000000001392] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Lian J, Deng C. The dosage-dependent effects of cevimeline in preventing olanzapine-induced metabolic side-effects in female rats. Pharmacol Biochem Behav 2020;191:172878. [PMID: 32112786 DOI: 10.1016/j.pbb.2020.172878] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Chen ZP, Zhang XY, Peng SY, Yang ZQ, Wang YB, Zhang YX, Chen X, Wang JJ, Zhu JN. Histamine H1 Receptor Contributes to Vestibular Compensation. J Neurosci 2019;39:420-33. [PMID: 30413645 DOI: 10.1523/JNEUROSCI.1350-18.2018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
31 Libowitz MR, Nurmi EL. The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children. Front Psychiatry 2021;12:623681. [PMID: 33776816 DOI: 10.3389/fpsyt.2021.623681] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Singh R, Bansal Y, Medhi B, Kuhad A. Antipsychotics-induced metabolic alterations: Recounting the mechanistic insights, therapeutic targets and pharmacological alternatives. Eur J Pharmacol 2019;844:231-40. [PMID: 30529195 DOI: 10.1016/j.ejphar.2018.12.003] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
33 Tiwari AK, Zhang D, Pouget JG, Zai CC, Chowdhury NI, Brandl EJ, Qin L, Freeman N, Lieberman JA, Meltzer HY, Kennedy JL, Müller DJ. Impact of histamine receptors H1 and H3 polymorphisms on antipsychotic-induced weight gain. The World Journal of Biological Psychiatry 2018;19:S97-S105. [DOI: 10.1080/15622975.2016.1262061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
34 Yang CP, Wang YY, Lin SY, Hong YJ, Liao KY, Hsieh SK, Pan PH, Chen CJ, Chen WY. Olanzapine Induced Dysmetabolic Changes Involving Tissue Chromium Mobilization in Female Rats. Int J Mol Sci 2019;20:E640. [PMID: 30717287 DOI: 10.3390/ijms20030640] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Sylvester E, Yi W, Han M, Deng C. Exercise intervention for preventing risperidone-induced dyslipidemia and gluco-metabolic disorders in female juvenile rats. Pharmacol Biochem Behav 2020;199:173064. [PMID: 33127383 DOI: 10.1016/j.pbb.2020.173064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Samy DM, Mostafa DK, Abdelmonsif DA, Ismail CA, Hassaan PS. Crosstalk of hypothalamic chemerin, histamine, and AMPK in diet-and olanzapine-induced obesity in rats. Life Sci 2021;284:119897. [PMID: 34450172 DOI: 10.1016/j.lfs.2021.119897] [Reference Citation Analysis]
37 Singh R, Bansal Y, Sodhi RK, Singh DP, Bishnoi M, Kondepudi KK, Medhi B, Kuhad A. Berberine attenuated olanzapine-induced metabolic alterations in mice: Targeting transient receptor potential vanilloid type 1 and 3 channels. Life Sci 2020;247:117442. [PMID: 32081663 DOI: 10.1016/j.lfs.2020.117442] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]